Catalyst Pharmaceuticals: The Journey From Earnings Euphoria To Patent Perils (CPRX)
ADragan/iStock via Getty Images Introduction Catalyst Pharmaceuticals (NASDAQ:CPRX) is a commercial-stage biopharmaceutical entity dedicated to in-licensing, developing, and marketing novel treatments for rare and challenging diseases. With a strong emphasis on patient needs, they specialize […]
